VitaNova Life Sciences (VNOV) Notes Payables (2017)

VitaNova Life Sciences (VNOV) posted Notes Payables of $6000.0 for Q2 2017.

VitaNova Life Sciences (VNOV) Notes Payables (2017) Analysis & Trends

VitaNova Life Sciences' Notes Payables history runs 1 years deep, the most recent figure standing at $6000.0 for Q2 2017.

  • Quarterly Notes Payables changed N/A year-over-year to $6000.0 in Q2 2017, while the trailing twelve-month figure through Apr 2017 was $6000.0 (changed N/A YoY) and the FY2017 annual result came in at $6000.0, changed N/A from the prior year.
  • Notes Payables was $6000.0 for Q2 2017 at VitaNova Life Sciences.
  • Across five years, Notes Payables topped out at $6000.0 in Q2 2017 and bottomed at $6000.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Mckesson 105.72 Bn 101.75 Bn 4.04 Bn
2 Cencora 60.96 Bn 58.79 Bn 3.59 Bn
3 Cardinal Health 53.93 Bn 49.99 Bn 2.50 Bn
4 Henry Schein 9.78 Bn 9.65 Bn 1.07 Bn
5 Akso Health 3.06 Bn 3.06 Bn -
6 111 651.73 Mn 572.63 Mn 23.58 Mn
7 Accendra Health 247.26 Mn -89.62 Mn 278.03 Mn
8 Edap Tms 230.14 Mn 215.14 Mn 8.15 Mn
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00
10 Cosmos Health 9.29 Mn 7.13 Mn 1.38 Mn

Historic Data

Download Data
DateValue
Apr 30, 2017 6,000.00